Novartis buys S Africa-based Aspen’s Japanese generic unit for up to $440m

Novartis buys S Africa-based Aspen’s Japanese generic unit for up to $440m

Photo: Reuters

Novartis is buying the Japanese generics unit of South Africa’s Aspen Pharmacare in a deal worth up to 400 millioneuros ($440.80 million) to expand in the world’s third-biggest drug market, the Swiss drugmaker said on Monday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter